Confirmation of a prognostic index in primary breast cancer.
about
High expression of Lewis y/b antigens is associated with decreased survival in lymph node negative breast carcinomasElevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomasPREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancerAn investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United KingdomThe Nottingham Prognostic Index: five- and ten-year data for all-cause survival within a screened population.Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data.Methodological challenges in the evaluation of prognostic factors in breast cancer.Routinely available indicators of prognosis in breast cancer.Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithmsA scoring system to predict breast cancer mortality at 5 and 10 yearsCancerous breast lesions on dynamic contrast-enhanced MR images: computerized characterization for image-based prognostic markers.American Joint Committee on Cancer prognostic factors consensus conference.A fuzzy gene expression-based computational approach improves breast cancer prognosticationNew prognostic histological parameter of invasive ductal carcinoma of the breast: clinicopathological significance of fibrotic focus.Role of axillary surgery in early breast cancer: review of the current evidence.External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.Preoperative assessment of prognostic factors in breast cancer.Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.Integration of clinical and gene expression data has a synergetic effect on predicting breast cancer outcomeA 1 Mb minimal amplicon at 8p11-12 in breast cancer identifies new candidate oncogenes.Late results of selective axillary surgery based on contact cytology in women with operable breast cancer.Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer.Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.Predictive and prognostic markers for invasive breast cancer.Estimation of prognosis of the individual with primary breast cancer and its applications.Explaining the difference in prognosis between screen-detected and symptomatic breast cancers.Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study.An evaluation of the prognostic model PREDICT using the POSH cohort of women aged ⩽40 years at breast cancer diagnosis.Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.Routine histoprognostic factors in early-stage breast carcinoma: a review.Modified primary tumour/vessel tumour/nodal tumour classification for patients with invasive ductal carcinoma of the breast.Estrogen Receptor, Progesterone Receptor, and Her-2/neu Oncogene Expression in Breast Cancers Among Bangladeshi WomenComparison of mastectomy with tamoxifen for treating elderly patients with operable breast cancer.Expression of receptor activator of nuclear factor kappabeta ligand (RANKL) and tumour necrosis factor related, apoptosis inducing ligand (TRAIL) in breast cancer, and their relations with osteoprotegerin, oestrogen receptor, and clinicopathologicalDiffusion-Weighted Imaging in 3.0 Tesla Breast MRI: Diagnostic Performance and Tumor Characterization Using Small Subregions vs. Whole Tumor Regions of InterestOestrogen receptor expression in ductal carcinoma in situ of the breast: relationship to flow cytometric analysis of DNA and expression of the c-erbB-2 oncoprotein.Defining a high mortality risk group among women with primary breast cancerThymidine kinase in breast cancer.Lacking prognostic significance of beta 2-microglobulin, MHC class I and class II antigen expression in breast carcinomas.c-erbB-2 oncoprotein expression in primary and advanced breast cancer
P2860
Q21195240-5DCFF2E6-87D0-4308-82FE-191615744DA4Q24559979-B8AC7702-18A0-42DB-8FB5-3CBDC48E9E17Q24600928-051040CC-7C05-4B06-8D8D-E928330C6A0AQ24648357-523DE5CC-D1FB-4FD7-90F9-94CC803B2B00Q30901414-D1D38E0F-2B7F-4637-99D4-04F98F8CB8ACQ31167768-40BC2E30-E785-4474-AE1A-4319011EB9BAQ33538459-F596070E-C057-4501-B138-854148704E93Q33539150-2ABC2C7B-A5E8-4666-A3CD-417006E3ADC5Q33651520-EDBBC67B-6B8D-4EBD-A04E-4A1D5D873B84Q33673226-F4B0EFA2-9EC1-4F41-9839-78E78B66E0FAQ33679786-F2A10427-5EDA-4367-A95C-A6B8DBF5CE2FQ33789795-EF27462E-7A4E-4969-8A46-BBB1A5134119Q33861620-44101535-089F-4732-A147-039EC1B81AE1Q33940503-C0516A33-C1EC-4BB7-9BC0-6755A52165CBQ33972653-DAF06030-F266-4563-9675-E2A12C17A6D0Q34075697-5FCC15CB-B37A-4E1E-8254-105F2DD6DF2CQ34197110-F0CD11AB-9FEE-454A-B938-98EA7EF872D6Q34253754-A23A528D-1F61-47F8-9414-C7B6D51BD8D7Q34341956-D63B68D6-C65F-4076-8D5C-010708032897Q34419358-64F558C4-3DE4-429A-AFF5-DE13C7E3B651Q34548290-AC8BB04D-8D41-4953-B0B9-B8A43AB262F0Q34563697-5778780C-6879-4ACB-99E7-B328B9829D8AQ34611172-D47C073E-CE37-4397-8E05-8242574B49E2Q34612314-32EF8F31-5A41-49E2-90E3-132476796C86Q35008184-D979068C-52F7-48EF-8CDC-B7D42286FA8FQ35034571-915F40C9-C372-4338-BEAF-EE70E8905A01Q35138699-BF3B9DB7-4CA6-476B-9E97-8017C6CEE53EQ35198352-D2544730-3A71-484A-BD72-972C72DA7697Q35208414-3CA14A35-69BD-4F10-8C58-6C8A0ADC6EDDQ35234908-11E6282F-C04F-4346-BF89-13C3FA0EC65AQ35287660-51A8512E-EA21-4EF1-BD1E-B741471C5D1CQ35688403-8170F69C-9EEE-4474-8960-36CBCFC28285Q35730625-BCE39B60-5103-4A46-8444-D5E1FF8734C1Q35770122-B9DE3207-65CD-4C2B-9918-7EFD05C04F29Q35803454-4ACC79FB-E663-44C8-ACAE-645747D95738Q35976349-FCA2E9C7-99CC-4ED7-BEA5-A11CA652AF77Q35978238-35D4778A-0B51-42DA-BC1F-5C77950B2203Q35982047-39EE3835-2A59-4883-9516-C656AAA078C2Q35983100-01713E0F-4928-4932-BADF-3681AC48FE3AQ35983286-B7A4F7BC-F8D9-4213-9D95-68C809D1040C
P2860
Confirmation of a prognostic index in primary breast cancer.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Confirmation of a prognostic index in primary breast cancer.
@ast
Confirmation of a prognostic index in primary breast cancer.
@en
type
label
Confirmation of a prognostic index in primary breast cancer.
@ast
Confirmation of a prognostic index in primary breast cancer.
@en
prefLabel
Confirmation of a prognostic index in primary breast cancer.
@ast
Confirmation of a prognostic index in primary breast cancer.
@en
P2093
P2860
P356
P1476
Confirmation of a prognostic index in primary breast cancer
@en
P2093
C P Hinton
C W Elston
J L Haybittle
M R Williams
R W Blamey
P2860
P2888
P304
P356
10.1038/BJC.1987.230
P407
P50
P577
1987-10-01T00:00:00Z